CLB logo

Core Laboratories NV (CLB) Current Liabilities

Annual Current Liabilities

$88.10 M
-$15.04 M-14.58%

31 December 2023

CLB Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$94.94 M
-$2.66 M-2.73%

30 September 2024

CLB Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLB Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-14.6%+12.7%
3 y3 years-1.8%+2.1%
5 y5 years-14.1%-20.9%

CLB Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-14.6%at low-8.0%+12.7%
5 y5 years-21.1%at low-44.9%+12.7%
alltimeall time-68.5%+520.4%-75.7%+704.6%

Core Laboratories NV Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$94.94 M(-2.7%)
June 2024
-
$97.60 M(+14.2%)
Mar 2024
-
$85.47 M(-3.0%)
Dec 2023
$88.10 M(-14.6%)
$88.10 M(+4.6%)
Sept 2023
-
$84.25 M(-12.4%)
June 2023
-
$96.19 M(+0.6%)
Mar 2023
-
$95.62 M(-7.3%)
Dec 2022
$103.14 M(+13.6%)
$103.14 M(+18.1%)
Sept 2022
-
$87.36 M(-8.9%)
June 2022
-
$95.91 M(-3.9%)
Mar 2022
-
$99.76 M(+9.9%)
Dec 2021
$90.78 M(+1.1%)
$90.78 M(-2.3%)
Sept 2021
-
$92.95 M(+2.3%)
June 2021
-
$90.85 M(+6.2%)
Mar 2021
-
$85.53 M(-4.7%)
Dec 2020
$89.75 M(-19.6%)
$89.75 M(-47.9%)
Sept 2020
-
$172.14 M(+73.4%)
June 2020
-
$99.28 M(-8.4%)
Mar 2020
-
$108.45 M(-2.8%)
Dec 2019
$111.59 M(+8.8%)
$111.59 M(-7.0%)
Sept 2019
-
$120.00 M(-3.9%)
June 2019
-
$124.83 M(-2.9%)
Mar 2019
-
$128.62 M(+25.4%)
Dec 2018
$102.55 M(+2.0%)
$102.55 M(-0.9%)
Sept 2018
-
$103.51 M(+2.9%)
June 2018
-
$100.59 M(-3.6%)
Mar 2018
-
$104.33 M(+3.7%)
Dec 2017
$100.58 M(-3.3%)
$100.58 M(+8.0%)
Sept 2017
-
$93.14 M(-7.6%)
June 2017
-
$100.81 M(-7.3%)
Mar 2017
-
$108.80 M(+4.6%)
Dec 2016
$104.02 M(-13.9%)
$104.02 M(+11.2%)
Sept 2016
-
$93.54 M(-2.8%)
June 2016
-
$96.22 M(-11.3%)
Mar 2016
-
$108.42 M(-10.2%)
Dec 2015
$120.76 M(-8.4%)
$120.76 M(-2.7%)
Sept 2015
-
$124.06 M(-9.4%)
June 2015
-
$136.88 M(+4.1%)
Mar 2015
-
$131.53 M(-0.3%)
Dec 2014
$131.87 M(-2.9%)
$131.87 M(+3.8%)
Sept 2014
-
$127.04 M(-5.1%)
June 2014
-
$133.92 M(-9.8%)
Mar 2014
-
$148.46 M(+9.3%)
Dec 2013
$135.78 M(-3.4%)
$135.78 M(-1.5%)
Sept 2013
-
$137.83 M(-2.2%)
June 2013
-
$140.96 M(-6.5%)
Mar 2013
-
$150.75 M(+7.3%)
Dec 2012
$140.51 M(-1.9%)
$140.51 M(+18.2%)
Sept 2012
-
$118.88 M(-5.8%)
June 2012
-
$126.18 M(-4.2%)
Mar 2012
-
$131.67 M(-8.0%)
Dec 2011
$143.19 M(-48.7%)
$143.19 M(-31.9%)
Sept 2011
-
$210.12 M(-11.0%)
June 2011
-
$236.10 M(-6.5%)
Mar 2011
-
$252.51 M(-9.6%)
Dec 2010
$279.35 M
$279.35 M(-13.6%)
Sept 2010
-
$323.40 M(-4.2%)
June 2010
-
$337.41 M(+2.6%)
DateAnnualQuarterly
Mar 2010
-
$328.81 M(+209.0%)
Dec 2009
$106.41 M(+11.2%)
$106.41 M(+24.3%)
Sept 2009
-
$85.61 M(+0.9%)
June 2009
-
$84.86 M(-2.1%)
Mar 2009
-
$86.65 M(-9.5%)
Dec 2008
$95.69 M(-2.4%)
$95.69 M(+1.4%)
Sept 2008
-
$94.38 M(-75.8%)
June 2008
-
$390.29 M(+317.5%)
Mar 2008
-
$93.48 M(-4.7%)
Dec 2007
$98.04 M(+10.3%)
$98.04 M(-14.7%)
Sept 2007
-
$114.96 M(+15.8%)
June 2007
-
$99.30 M(+19.1%)
Mar 2007
-
$83.38 M(-6.2%)
Dec 2006
$88.92 M(+27.8%)
$88.92 M(+2.8%)
Sept 2006
-
$86.51 M(+6.8%)
June 2006
-
$81.00 M(+10.0%)
Mar 2006
-
$73.66 M(+5.9%)
Dec 2005
$69.56 M(+3.2%)
$69.56 M(+4.9%)
Sept 2005
-
$66.29 M(+4.2%)
June 2005
-
$63.60 M(-2.2%)
Mar 2005
-
$65.06 M(-3.5%)
Dec 2004
$67.41 M(+8.9%)
$67.41 M(+14.1%)
Sept 2004
-
$59.06 M(-0.1%)
June 2004
-
$59.09 M(+6.3%)
Mar 2004
-
$55.61 M(-10.1%)
Dec 2003
$61.87 M(+23.5%)
$61.87 M(+15.0%)
Sept 2003
-
$53.82 M(-2.5%)
June 2003
-
$55.21 M(+17.8%)
Mar 2003
-
$46.85 M(-6.5%)
Dec 2002
$50.08 M(+25.2%)
$50.08 M(+53.6%)
Sept 2002
-
$32.60 M(+1.7%)
June 2002
-
$32.06 M(+5.8%)
Mar 2002
-
$30.29 M(-24.3%)
Dec 2001
$40.01 M(-27.6%)
$40.01 M(-11.3%)
Sept 2001
-
$45.09 M(-4.0%)
June 2001
-
$46.98 M(+2.5%)
Mar 2001
-
$45.85 M(-17.0%)
Dec 2000
$55.27 M(+6.7%)
$55.27 M(+40.1%)
Sept 2000
-
$39.44 M(-10.4%)
June 2000
-
$44.03 M(-11.6%)
Mar 2000
-
$49.82 M(-3.8%)
Dec 1999
$51.80 M(-22.5%)
$51.80 M(+12.8%)
Sept 1999
-
$45.90 M(-15.3%)
June 1999
-
$54.20 M(-13.1%)
Mar 1999
-
$62.40 M(-6.6%)
Dec 1998
$66.80 M(+31.8%)
$66.80 M(+35.5%)
Sept 1998
-
$49.30 M(-16.3%)
June 1998
-
$58.90 M(+50.3%)
Mar 1998
-
$39.20 M(-22.7%)
Dec 1997
$50.70 M(+193.1%)
$50.70 M(+1.0%)
Sept 1997
-
$50.20 M(+3.9%)
June 1997
-
$48.30 M(+126.8%)
Mar 1997
-
$21.30 M(+23.1%)
Dec 1996
$17.30 M(+21.8%)
$17.30 M(+46.6%)
Sept 1996
-
$11.80 M(-7.8%)
June 1996
-
$12.80 M(-8.6%)
Mar 1996
-
$14.00 M(-1.4%)
Dec 1995
$14.20 M
$14.20 M(+4.4%)
Sept 1995
-
$13.60 M

FAQ

  • What is Core Laboratories NV annual total current liabilities?
  • What is the all time high annual current liabilities for Core Laboratories NV?
  • What is Core Laboratories NV annual current liabilities year-on-year change?
  • What is Core Laboratories NV quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Core Laboratories NV?
  • What is Core Laboratories NV quarterly current liabilities year-on-year change?

What is Core Laboratories NV annual total current liabilities?

The current annual current liabilities of CLB is $88.10 M

What is the all time high annual current liabilities for Core Laboratories NV?

Core Laboratories NV all-time high annual total current liabilities is $279.35 M

What is Core Laboratories NV annual current liabilities year-on-year change?

Over the past year, CLB annual total current liabilities has changed by -$15.04 M (-14.58%)

What is Core Laboratories NV quarterly total current liabilities?

The current quarterly current liabilities of CLB is $94.94 M

What is the all time high quarterly current liabilities for Core Laboratories NV?

Core Laboratories NV all-time high quarterly total current liabilities is $390.29 M

What is Core Laboratories NV quarterly current liabilities year-on-year change?

Over the past year, CLB quarterly total current liabilities has changed by +$10.69 M (+12.69%)